Searched for
PASHAMYLARAM FACILITY
Sigachi Industries cuts death toll to 39 from factory blast in TelanganaSigachi Industries confirmed 39 deaths in the Telangana factory explosion. This brings the count down from the earlier reported 40. Twelve ...
Telangana-based Sigachi Industries says 40 team members killed and 33 injured in explosion & fireA tragic accident occurred at Sigachi Industries' Pashamylaram plant in Telangana. Forty team members died, and thirty-three were injured i...
Telangana factory blast: 40 killed, 33 injured, confirms Sigachi IndustriesSigachi Industries reported a deadly explosion at its Pashamylaram facility on Wednesday, resulting in 40 deaths and at least 33 injuries. ...
Telangana pharma plant explosion: Sigachi says unit fully insured, assures support to affected personsA blast at Sigachi Industries' Pashamylaram unit in Telangana resulted in twelve deaths. Production will halt for ninety days. The company ...
Sigachi temporarily suspends production at Hyderabad unit for 90 days after fire incidentA fire at Sigachi Industries' Hyderabad plant on June 30, 2025, resulted in fatalities and injuries, prompting a 90-day production halt for...
Sigachi Industries shares plunge 15% after explosion at Telangana plantShares of Sigachi Industries plunged 14.8% to Rs 47 on Monday after a massive explosion and fire at its pharmaceutical plant in Telangana’s...
At least 12 dead in massive reactor blast at Sigachi Industries unit in Telangana’s PashamylaramA massive reactor explosion at Sigachi Industries in Telangana's Pashamylaram resulted in at least 8 fatalities and several injuries. The b...
Gland Pharma Q3 net profit rises 7% to Rs 205 croreGland Pharma on Monday reported 7% year-on-year (YoY) rise in net profit to Rs 205 crores in Q3FY25.
USFDA flags Telangana unit of Aurobindo Pharma armThe letter, issued on August 15, was later made public by the USFDA, which stated that there was failure to ensure the accuracy of data in ...
Stocks in news: HDFC Life, SBI, LTI Mindtree, Gland Pharma, VedantaForeign entity WWD Ruby Ltd has offloaded its entire 4.77% stake in Sapphire Foods India Ltd through the open market on Tuesday for Rs 417 ...
Gland Pharma's Hyderabad unit gets one observation from USFDA after inspection"This observation is procedural in nature and the corrective and preventive actions for this observation will be submitted to the USFDA wit...
Gland Pharma net profit down 72% to Rs 79 crore in Q4FY23Gland Pharma on Thursday reported 72% year-on-year (YoY) drop in net profit to Rs 79 crores in Q4FY23 due to production shutdown at one of ...
Suven Pharma Q2 results: Net profit declines 20% to Rs 74 crConsolidated total income of the company stood at Rs 237.74 crore for the quarter under consideration. It was Rs 278.37 crore for the same ...
Aurobindo Pharma plunges 9% as USFDA issues 14 observationsThe Unit IV of the facility was inspected by USFDA from November 4 to November 13.
Aurobindo Pharma gets 8 observations for 2 plants from USFDAThe company will be responding to the USFDA as per the prescribed time lines, the drug firm said.
Aurobindo Pharma under USFDA scrutinyAurobindo has seen intense scrutiny on the manufacturer process of valsartan, an anti-hypertension drug, that was found to contain carcinog...
Suven Life Sciences' Pashamylaram facility successfully completes USFDA inspectionThe facility has undergone renewal inspection from February 5-18 by the United States Food and Drug Administration (USFDA), Suven Life Scie...
Suven Life receives Establishment Inspection Report from USFDASuven Life Sciences said so far it has filed 19 DMF's and 4 ANDA's from its plant near Hyderabad which is FDA complaint.
- Suven Life Sciences manufacturing facility gets USFDA approval
Suven Life Sciences today said it has received the US health regulator''s approval for its active pharmaceutical ingredients.
- Suven Life lines up $45-m expansion
Suven Lifesciences, is planning to scale up its drug discovery development and support services.